Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Bone Metastasis

  • Robert L. Satcher
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_7224-1

Synonyms

Definition

A metastasis is a tumor that is established by the spread of cancer from the part of the body where it started (primary site) to another part of the body (Mundy 2002). Bone metastases consist of a solid mass inside the bone that spread from a distant tumor. They usually cause pain (Jimenez-Andrade et al. 2010). Metastases can occur in any bone in the body, but are most often found in bones near the center of the body, such as the spine, pelvis, ribs, upper femur, upper arm, and skull. Once cancer has spread to the bones, it is rarely able to be cured (Coleman 2006; Mundy 2002).

Characteristics

There are approximately 100,000 cancer patients diagnosed with bone metastasis in the USA each year. The usual presenting symptom is pain characterized by a dull, constant ache with periodic spikes of incident pain (Coleman et al. 2008). The bone is the third most common location for metastasis, after...

Keywords

Prostate Cancer Bone Metastasis Spinal Cord Compression Kidney Cancer Skeletal Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. Anselmetti GC (2010) Osteoplasty: percutaneous bone cement injection beyond the spine. Semin Interv Radiol 27:199–208CrossRefGoogle Scholar
  2. Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s–6249sPubMedCrossRefGoogle Scholar
  3. Coleman RE, Guise TA, Lipton A, Roodman GD, Berenson JR, Body JJ, Boyce BF, Calvi LM, Hadji P, McCloskey EV, Saad F, Smith MR, Suva LJ, Taichman RS, Vessella RL, Weilbaecher KN (2008) Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference. Clin Cancer Res 14:6387–6395PubMedPubMedCentralCrossRefGoogle Scholar
  4. Finlay IG, Mason MD, Shelley M (2005) Radioisotopes for the palliation of metastatic bone cancer: a systematic review. Lancet Oncol 6:392–400PubMedCrossRefGoogle Scholar
  5. Guise T (2010) Examining the metastatic niche: targeting the microenvironment. Semin Oncol 37(Suppl 2):S2–S14PubMedCrossRefGoogle Scholar
  6. Halvorson KG, Sevcik MA, Ghilardi JR, Rosol TJ, Mantyh PW (2006) Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer. Clin J Pain 22:587–600PubMedCrossRefGoogle Scholar
  7. Henry DH, Costa L, Goldwasser F, Hirsh V, Hungria V, Prausova J, Scagliotti GV, Sleeboom H, Spencer A, Vadhan-Raj S, von Moos R, Willenbacher W, Woll PJ, Wang J, Jiang Q, Jun S, Dansey R, Yeh H (2011) Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol 29:1125–1132PubMedCrossRefGoogle Scholar
  8. Jacofsky DJ, Papagelopoulos PJ, Sim FH (2003) Advances and challenges in the surgical treatment of metastatic bone disease. Clin Orthop Relat Res 415:S14–S18PubMedCrossRefGoogle Scholar
  9. Jimenez-Andrade JM, Mantyh WG, Bloom AP, Ferng AS, Geffre CP, Mantyh PW (2010) Bone cancer pain. Ann N Y Acad Sci 1198:173–181PubMedCrossRefGoogle Scholar
  10. Lipton A, Berenson JR, Body JJ, Boyce BF, Bruland OS, Carducci MA, Cleeland CS, Clohisy DR, Coleman RE, Cook RJ, Guise TA, Pearse RN, Powles TJ, Rogers MJ, Roodman GD, Smith MR, Suva LJ, Vessella RL, Weilbaecher KN, King L (2006) Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference. Clin Cancer Res 12:6209s–6212sPubMedPubMedCentralCrossRefGoogle Scholar
  11. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584–593PubMedCrossRefGoogle Scholar
  12. Neville-Webbe HL, Coleman RE (2010) Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease. Eur J Cancer 46:1211–1222PubMedCrossRefGoogle Scholar
  13. Shiozawa Y, Eber MR, Berry JE, Taichman RS (2015) Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors. Bonekey Rep 4:689PubMedCrossRefGoogle Scholar
  14. Sterling JA, Edwards JR, Martin TJ, Mundy GR (2011) Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone 48:6–15PubMedCrossRefGoogle Scholar
  15. Teitelbaum SL (2007) Osteoclasts: what do they do and how do they do it? Am J Pathol 170:427–435PubMedPubMedCentralCrossRefGoogle Scholar
  16. Zhang S, Wang J, Bilen MA, Lin SH, Stupp SI, Satcher RL (2009) Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts. Clin Exp Metastasis 26:993–1004PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Orthopaedic OncologyUniversity of Texas, M.D. Anderson Cancer CenterHoustonUSA